As of 2024-12-12, the Intrinsic Value of Celadon Pharmaceuticals PLC (CEL.L) is (744.69) GBP. This CEL.L valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 19.00 GBP, the upside of Celadon Pharmaceuticals PLC is -4,019.40%.
The range of the Intrinsic Value is (1,100.60) - (560.88) GBP
Note: result may not be accurate due to the invalid valuation result of DCF model.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (1,100.60) - (560.88) | (744.69) | -4019.4% |
| DCF (Growth 10y) | (1,006.74) - (496.82) | (669.50) | -3623.7% |
| Fair Value | -41.80 - -41.80 | -41.80 | -319.99% |
| EPV | (1,425.25) - (648.47) | (1,036.86) | -5557.2% |
| DDM - Stable | (2,107.74) - (296.81) | (1,202.28) | -6427.8% |
| DDM - Multi | (3,909.94) - (388.93) | (735.02) | -3968.5% |
| Market Cap (mil) | 11.89 |
| Beta | -4.82 |
| Outstanding shares (mil) | 0.63 |
| Enterprise Value (mil) | 16.65 |
| Market risk premium | 5.98% |
| Cost of Equity | 2.41% |
| Cost of Debt | 4.58% |
| WACC | 3.05% |